Trader Peter Brandt Revises Ethereum (ETH) Bearish View; InQubeta (QUBE) & Injective (INJ) Beckon as an Exciting Opportunity

Trader Peter Brandt Revises Ethereum (ETH) Bearish View; InQubeta (QUBE) & Injective (INJ) Beckon as an Exciting Opportunity

Last updated: January 5, 2024 23:28 EST
. 3 min read

Disclosure: Crypto is a high-risk asset class. This article is provided for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions. We may utilise affiliate links within our content, and receive commission.

ETHETH

Ethereum (ETH) recently hit the headlines after veteran crypto trader Peter Brandt said that the bearish predictions about the cryptocurrency over an ascending triangle chart pattern were not correct.

Brandt contradicted the prediction due to a recent rise above an ascending triangle wedge pattern in Ethereum’s price chart. The wedge pattern is marked by trend lines connecting the highs and lows of a price series.

In other news, InQubeta (QUBE) and Injective (INJ) have been posting impressive growth. While Injective is a decentralized protocol for managing assets, InQubeta is an Ethereum-based platform that helps startups raise funds for AI projects.

In a short period, InQubeta has gained an edge over other altcoins and has made a splash globally. Its cryptocurrency ICO has so far raised $7.8 million.

InQubeta: Where startup finance meets blockchain



InQubeta has been designed for startups who believe in artificial intelligence’s potential to disrupt the future. The decentralized platform supports startups who have put projects on the backburner due to a fund shortage.

It has emerged as one of the best altcoins for 2023 by demonstrating the far-reaching impact of DeFi. InQubeta’s native cryptocurrency QUBE is the official medium of exchange for the network. The QUBE token is powered by the ERC-20 standard.

While the InQubeta team has generated 1.5 billion QUBE tokens, only 65% of the total supply will be used for public sale. What’s left will go towards operating the platform and for meeting expenses like legal fees, paying developers, marketing activities, distributing rewards, and infusing liquidity into the platform.

The QUBE token has a multi-faceted model which includes a deflationary character. Due to limited availability, the token demand remains high despite inflation. If there is a sudden hike in supply, the excess tokens are burned to make it scarce again.

InQubeta leverages a decentralized autonomous organizations (DAO) model to distribute the responsibilities of decisions. Such a model brings together community members to decide on key matters. If a stakeholder thinks of a protocol change, it’s pitched as a proposal.

All proposals have to undergo a review process and are then put to a vote. QUBE token holders have special voting rights to participate in the process. They help prevent unnecessary changes by exercising good judgment.

The AI sector is an upcoming industry and InQubeta could gain an early mover advantage by providing startups with easy access to funds.

Injective to host ‘End of the Year Treasure Hunt’



Injective is a Layer 1 blockchain that can help developers create future-ready dApps. Its native token is represented by the ticker INJ. Injective’s stellar performance in the past has drawn the attention of crypto users worldwide and it’s now considered an unmissable opportunity.

It recently hit the headlines after it announced its plans to host the ‘End of the Year Treasure Hunt’. The competition invites participants to discover 12 hidden words. The Top 3 players will share a prize pool and other goodies. The prize pool is supported by Injective-related dApps.

The participants will have to interact with the dApps, complete tasks, and find the secret words.

Ethereum co-founder Vitalik Buterin shares revised roadmap



Recommended by experts as a top crypto to invest in, Ethereum is a leading blockchain technology that supports a wide range of decentralized infrastructures including sidechains, dApps, and cryptocurrencies. Its native token ETH is used for settling all payments on the network. These transactions are validated using the proof-of-stake consensus protocol.

Analysts who have been closely monitoring Ethereum’s performance have an optimistic view of its prospects. Recently, noted crypto trader Peter Brandt also revised his outlook and said the recent bearish predictions about the ETH token might not be correct as the cryptocurrency’s price had managed to move above an ascending triangle pattern.

In a recent development, Ethereum co-founder Vitalik Buterin also shared a revised roadmap for the cryptocurrency. Buterin did not specify a deadline or time frame for the roadmap. According to reports, the updated roadmap will tackle Ethereum’s design weakness which has prompted a surge in Layer 2 networks.

Conclusion



Ethereum, InQubeta, and Injective have braved the flurry of new altcoins in 2023 with their robust performances. The three cryptocurrencies added more zeros to their patrons’ bank balances with their cutting-edge features and high growth potential.

Analysts’ recent predictions about the three tokens reflect their optimism. If you are looking to ramp up your crypto portfolio this year, these cryptocurrencies might be just what you need.

Visit InQubeta Presale

Trader Peter Brandt Revises Ethereum (ETH) Bearish View; InQubeta (QUBE) & Injective (INJ) Beckon as an Exciting Opportunity

Last updated: January 5, 2024 23:28 EST
. 3 min read

Disclosure: Crypto is a high-risk asset class. This article is provided for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions. We may utilise affiliate links within our content, and receive commission.

ETHETH

Ethereum (ETH) recently hit the headlines after veteran crypto trader Peter Brandt said that the bearish predictions about the cryptocurrency over an ascending triangle chart pattern were not correct.

Brandt contradicted the prediction due to a recent rise above an ascending triangle wedge pattern in Ethereum’s price chart. The wedge pattern is marked by trend lines connecting the highs and lows of a price series.

In other news, InQubeta (QUBE) and Injective (INJ) have been posting impressive growth. While Injective is a decentralized protocol for managing assets, InQubeta is an Ethereum-based platform that helps startups raise funds for AI projects.

In a short period, InQubeta has gained an edge over other altcoins and has made a splash globally. Its cryptocurrency ICO has so far raised $7.8 million.

InQubeta: Where startup finance meets blockchain



InQubeta has been designed for startups who believe in artificial intelligence’s potential to disrupt the future. The decentralized platform supports startups who have put projects on the backburner due to a fund shortage.

It has emerged as one of the best altcoins for 2023 by demonstrating the far-reaching impact of DeFi. InQubeta’s native cryptocurrency QUBE is the official medium of exchange for the network. The QUBE token is powered by the ERC-20 standard.

While the InQubeta team has generated 1.5 billion QUBE tokens, only 65% of the total supply will be used for public sale. What’s left will go towards operating the platform and for meeting expenses like legal fees, paying developers, marketing activities, distributing rewards, and infusing liquidity into the platform.

The QUBE token has a multi-faceted model which includes a deflationary character. Due to limited availability, the token demand remains high despite inflation. If there is a sudden hike in supply, the excess tokens are burned to make it scarce again.

InQubeta leverages a decentralized autonomous organizations (DAO) model to distribute the responsibilities of decisions. Such a model brings together community members to decide on key matters. If a stakeholder thinks of a protocol change, it’s pitched as a proposal.

All proposals have to undergo a review process and are then put to a vote. QUBE token holders have special voting rights to participate in the process. They help prevent unnecessary changes by exercising good judgment.

The AI sector is an upcoming industry and InQubeta could gain an early mover advantage by providing startups with easy access to funds.

Injective to host ‘End of the Year Treasure Hunt’



Injective is a Layer 1 blockchain that can help developers create future-ready dApps. Its native token is represented by the ticker INJ. Injective’s stellar performance in the past has drawn the attention of crypto users worldwide and it’s now considered an unmissable opportunity.

It recently hit the headlines after it announced its plans to host the ‘End of the Year Treasure Hunt’. The competition invites participants to discover 12 hidden words. The Top 3 players will share a prize pool and other goodies. The prize pool is supported by Injective-related dApps.

The participants will have to interact with the dApps, complete tasks, and find the secret words.

Ethereum co-founder Vitalik Buterin shares revised roadmap



Recommended by experts as a top crypto to invest in, Ethereum is a leading blockchain technology that supports a wide range of decentralized infrastructures including sidechains, dApps, and cryptocurrencies. Its native token ETH is used for settling all payments on the network. These transactions are validated using the proof-of-stake consensus protocol.

Analysts who have been closely monitoring Ethereum’s performance have an optimistic view of its prospects. Recently, noted crypto trader Peter Brandt also revised his outlook and said the recent bearish predictions about the ETH token might not be correct as the cryptocurrency’s price had managed to move above an ascending triangle pattern.

In a recent development, Ethereum co-founder Vitalik Buterin also shared a revised roadmap for the cryptocurrency. Buterin did not specify a deadline or time frame for the roadmap. According to reports, the updated roadmap will tackle Ethereum’s design weakness which has prompted a surge in Layer 2 networks.

Conclusion



Ethereum, InQubeta, and Injective have braved the flurry of new altcoins in 2023 with their robust performances. The three cryptocurrencies added more zeros to their patrons’ bank balances with their cutting-edge features and high growth potential.

Analysts’ recent predictions about the three tokens reflect their optimism. If you are looking to ramp up your crypto portfolio this year, these cryptocurrencies might be just what you need.

Visit InQubeta Presale

Exit mobile version